Brutalist Biotech
Max
3
|
5
|
10
|
20
items per feed.
Cutting-edge Biotech news: Presented the old-fashioned way.
Fierce Biotech
Small pools, big ideas: How the rare disease community is reimagining clinical trials
(12h)
RyghtAI launches clinical site search engine to aid drug developers, CROs with trial design
(15h)
'Absent or trivial' effects: Anti-amyloid Alzheimer's drugs called into question once again
(18h)
BioPharma Dive
Kailera nets $625M in one of biotech’s biggest-ever IPOs
(8h)
Erica Schwartz, ex-deputy surgeon general, picked to be next CDC director
(10h)
FDA moves toward easing restrictions on certain peptides
(17h)
Endpoints News
RFK Jr. defends FDA, Makary following Republican questions
(13h)
OpenAI launches biopharma-focused AI model to compete with Anthropic
(13h)
Cochrane review dismissing amyloid drugs draws immediate backlash
(16h)
BioSpace
Merck’s PD-1/VEGF data star in stacked lineup of AACR ‘26 data reveals
(4h)
Funding the Future of European Biotech
(10h)
Trump nominates new CDC director, appoints various leaders to embattled agency
(10h)
STAT News
Health care is not ready for the new era of AI-enabled cyberattacks
(12m)
Don’t believe headlines saying that vaccine skepticism is widespread
(12m)
HaloMD’s legal win highlights the difficulty of challenging arbitration decisions
(10h)
BioPharma Trend
Novo Nordisk and OpenAI Team Up to Integrate AI from Discovery to Supply Chain
(2d)
Life Biosciences Gets $80M as Cellular Rejuvenation Enters the Clinic
(1w)
Jeito Closes €1B Fund, Europe's Largest Independent Biopharma Raise
(1w)
Drug Channels
Mapping the Vertical Integration of Insurers, PBMs, GPOs, Specialty Pharmacies, and Healthcare Services: DCI’s 2026 Update
(2d)
Informa Connect’s Life Sciences Pricing & Contracting USA
(4d)
The Net Pricing Revolution in the Drug Channel: What’s Deflating the Gross-to-Net Bubble (rerun)
(6d)
European Biotechnology Magazine
Proteins.1 launches with €4.7m to make protein detection as easy as PCR
(19h)
Spain plants US$200m flag in Boston with debut US biotech fund
(1d)
Novo Nordisk is going all in on AI
(2d)
Drug Hunter
BMS-986482
(18h)
FBXO22: An Emerging E3 Ligase for TPD
(1d)
BHV-2100
(2d)
Labiotech.EU
Argobio: the venture model building Europe’s next biotech champions
(42m)
Eight allergy companies to watch in 2026
(1d)
Mending university and venture capital relations: is it possible to see eye-to-eye?
(2d)
Bio IT World
SPT Labtech and EMBL GeneCore Team Up for Fully Walkaway Automated Genomics Workflows
(1d)
AWS Launches Agentic Drug Discovery-Wet Lab Pipeline
(1d)
PARTAGE Method Reveals Genome Regulation in Single Approach
(3d)
GEN News
Stem Cell Editing Programs the Immune System to Make Own Therapeutic Proteins
(7h)
Intercellular Communication via Condensate Corona-Nanoparticle Complexes
(13h)
Brain Circuits Underlying Placebo Pain Relief Identified in Mice
(14h)
Cure Today
Treating Metastatic TNBC: Dr. Hope Rugo on ADCs and Personalized Therapy
(4w)
Understanding High-Risk Essential Thrombocythemia
(4w)
Son’s Decision to Donate Gave His Father a Second Chance
(4w)
Contract Pharma
Mabwell Secures Strategic License and Commercialization Agreement for Denosumab Biosimilars in Malaysia
(13h)
Harbour BioMed Appoints Adam Zong, PhD, President
(15h)
BioMed X France Launches First Research Team on Servier’s R&D Campus
(16h)
Pharma Times
Transgene completes randomisation in phase 2 trial of tg4050
(4d)
Bayer wins MHRA approval for Kerendia in heart failure
(4d)
Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
(1w)
Medcity News
Wisp, Visby Partner to Expand Access to At-Home STI Test
(11h)
CMS’ New ‘App Store’ Is Trying to Turn Interoperability Into a Digital Health Distribution System
(11h)
Startup Nula Emerges to Advance a New Class Medicines for Metabolic Disease
(13h)
Chemical & Engineering News
Iran war is benefiting some European chemical makers
(13h)
ACS Colloid and Surface Science Symposium turns 100
(15h)
Blood-brain barrier integrity depends on a glycan-cleaving enzyme
(19h)
The Pharma Letter
Ryght AI introduces world’s first, free, AI-powered clinical trial site search engine
(46m)
MeiraGTx reacquires bota-vec rights and prices public offering
(10h)
Alethio Therapeutics unveils ATX-011, a breakthrough for treating essential thrombocythemia
(17h)
Targeted Oncology
Ozekibart Plus Chemo Shows Promising Activity in R/R Ewing Sarcoma
(1mo)
Reduced CRS Rates Support Wider Adoption of Bispecifics in Myeloma
(1mo)
GLSI-100 Vaccine Shows <1% Annual Recurrence Rate in Phase 3 Breast Cancer Trial
(1mo)
MedWatch
Novo Nordisk's Wegovy tablet continues to gain US market share
(9m)
Eli Lilly to submit diabetes pill for US approval this quarter
(34m)
New study: Weight-loss medication may be effective against arthritis
(54m)
In The Pipeline
Anti-Amyloid Antibodies for Alzheimer: You Already Know
(12h)
Antimalarial Drugs Stepping On Each Other's Toes
(1d)
Answers and Reasons and Knowing and Thinking
(2d)
Pharmaphorum
UK says it has hit target on commercial trial set-up times
(12h)
Lift for UK healthtech as fund bags £100m from national bank
(18h)
FDA accelerated approval path needs improvement, says ICER
(19h)
Drug Discovery Weekly
Supercomputing collaboration to advance dermatology research
(42m)
Asgard Therapeutics appoints Dr Wolfram Brugger as CMO
(17h)
Novel therapy could slow tumour growth, results find
(19h)
HIT Consultant
Automating Behavioral Health Utilization Review to Reduce Denials
(1h)
Why AMA Data Shows Physician Burnout is No Longer a ‘One-Size-Fits-All’ Crisis
(11h)
Keebler Health Secures $16M to Scale LLM-Native Risk Adjustment Platform
(12h)
Insights: Pink Sheet
Japan Q1 Roundup Podcast: Iran War Impact, Divestments, Product Approvals
(3h)
Japan Pricing Roundup: Rapid Idvynso Reimbursement, CEA Cut For Briviact
(8h)
US FDA’s Principal Deputy Commissioner Moving To HHS As Senior Counselor For Public Health
(10h)
BioXconomy
Storm Therapeutics strikes sarcomas with $56m Series C thunder
(15m)
Compliance updates—OPDP, EU regulatory, CSRD and 340B
(11h)
Avanos Medical to begin a new chapter: Acquired by AIP in $1.27bn deal
(16h)
BioCentury
Autoimmune T cell engagers diverge from their oncology roots
(8h)
Scala Biodesign: embedding biologic design into pharma R&D workflows
(9h)
Now in clinic, Neomorph heads into AACR with $100M series B: Venture Report
(10h)
SCRIP
Japan Q1 Roundup Podcast: Iran War Impact, Divestments, Product Approvals
(5h)
Lilly To Head To FDA After Demonstrating Foundayo’s Cardiovascular, Liver Safety
(12h)
Storm Raises $56m To Take RNA Modification Inhibitor Into Phase II
(16h)